Literature DB >> 15625577

cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type VI.

Jiayi Zhang1, Jianliang Dai, Enpeng Zhao, Yun Lin, Li Zeng, Jinzhong Chen, Huari Zheng, Yu Wang, Xin Li, Kang Ying, Yi Xie, Yumin Mao.   

Abstract

Peptidylarginine deiminase (PAD) catalyzes the post-translational modification of protein through the conversion of arginine to citrulline in the presence of calcium ions. Human, similar to rodents, has four isoforms of PAD (type I, II, III and IV/V), each of which is distinct in substrate specificity and tissue specific expression. In our large-scale sequencing project, we identified a new human PAD cDNA from a human fetal brain cDNA library. The putative protein encoded by this cDNA is designated hPADVI. Expression analysis of hPADVI showed that it is mainly expressed in adult human ovary and peripheral blood leukocytes. We conclude that hPADVI may be orthologous to mouse ePAD, basing on sequence comparison, chromosome localization and exon-intron structure analysis. PAD-mediated deimination of epithelial cell keratin resulting in cytoskeletal remodeling suggests a possible role for hPADVI in cytoskeletal reorganization in the egg and in early embryo development. This study describes a new important member of the human PAD family.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15625577     DOI: 0451041051

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  16 in total

1.  Genome-scale gene expression characteristics define the follicular initiation and developmental rules during folliculogenesis.

Authors:  Kerong Shi; Feng He; Xuefeng Yuan; Yaofeng Zhao; Xuemei Deng; Xiaoxiang Hu; Ning Li
Journal:  Mamm Genome       Date:  2013-06-28       Impact factor: 2.957

2.  Phosphorylation-dependent interaction of tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein (YWHA) with PADI6 following oocyte maturation in mice.

Authors:  Alan J Snow; Pawan Puri; Amparo Acker-Palmer; Tewis Bouwmeester; Srinivasan Vijayaraghavan; Douglas Kline
Journal:  Biol Reprod       Date:  2008-05-07       Impact factor: 4.285

Review 3.  Rheumatoid arthritis and citrullination.

Authors:  Erika Darrah; Felipe Andrade
Journal:  Curr Opin Rheumatol       Date:  2018-01       Impact factor: 5.006

4.  PADI4 and tumourigenesis.

Authors:  Xiaotian Chang; Kehua Fang
Journal:  Cancer Cell Int       Date:  2010-03-12       Impact factor: 5.722

5.  Mining the Human Tissue Proteome for Protein Citrullination.

Authors:  Chien-Yun Lee; Dongxue Wang; Mathias Wilhelm; Daniel P Zolg; Tobias Schmidt; Karsten Schnatbaum; Ulf Reimer; Fredrik Pontén; Mathias Uhlén; Hannes Hahne; Bernhard Kuster
Journal:  Mol Cell Proteomics       Date:  2018-04-02       Impact factor: 5.911

6.  The synovium in rheumatoid arthritis.

Authors:  Carol A Hitchon; Hani S El-Gabalawy
Journal:  Open Rheumatol J       Date:  2011-12-30

Review 7.  Redox-Mediated Carbamylation As a Hapten Model Applied to the Origin of Antibodies to Modified Proteins in Rheumatoid Arthritis.

Authors:  Maria Isabel Trejo-Zambrano; Eduardo Gómez-Bañuelos; Felipe Andrade
Journal:  Antioxid Redox Signal       Date:  2021-06-04       Impact factor: 7.468

8.  Protein methylation is required to maintain optimal HIV-1 infectivity.

Authors:  Nicole M Willemsen; Eleanor M Hitchen; Tracey J Bodetti; Ann Apolloni; David Warrilow; Sabine C Piller; David Harrich
Journal:  Retrovirology       Date:  2006-12-15       Impact factor: 4.602

9.  A Critical Reappraisal of Neutrophil Extracellular Traps and NETosis Mimics Based on Differential Requirements for Protein Citrullination.

Authors:  Maximilian F Konig; Felipe Andrade
Journal:  Front Immunol       Date:  2016-11-04       Impact factor: 7.561

10.  Functional roles of the non-catalytic calcium-binding sites in the N-terminal domain of human peptidylarginine deiminase 4.

Authors:  Yi-Liang Liu; I-Chen Tsai; Chia-Wei Chang; Ya-Fan Liao; Guang-Yaw Liu; Hui-Chih Hung
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.